Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine

Current cancer immunotherapies predominantly rely on CD8(+) T cells to fight against tumors. However accumulative evidence showed that proinflammatory CD4(+) helper T cells are critical determinants of effective antitumor immunity. The utilization of universal tumor-reactive helper peptides from tel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Adotévi, Olivier, Dosset, Magalie, Galaine, Jeanne, Beziaud, Laurent, Godet, Yann, Borg, Christophe
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Commentary
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899142/
https://ncbi.nlm.nih.gov/pubmed/23357860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23587
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items